drugset / Trial / NCT06999083
A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants
RandomizedSequentialQuadruple-blindOther
Summary
The aim of this study is to investigate the safety and tolerability of HB0043 in healthy subjects following single-dose.
Timeline
- Start
- 2025-06-03
- Primary completion
- 2026-02-12
- Completion
- 2026-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HB0043 | Monoclonal antibody | — | — |
Indications
No indication recorded.